The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more
- PMID: 2644929
- DOI: 10.1001/archopht.1989.01070010250031
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more
Abstract
The four-year incidence and progression of retinopathy were investigated in a population-based sample of people with diabetes diagnosed at 30 years of age or older. For insulin users, 73 (47%) of the 154 who did not have any retinopathy at the first visit developed it in the four-year interval, and 31 (7%) of the 418 free of proliferative retinopathy developed it. Worsening of retinopathy occurred in a total of 34% (142/418). For nonusers of insulin, corresponding rates were 34% (110/320) for incidence of any retinopathy, 2% (11/486) for developing proliferative retinopathy, and 25% (121/486) for worsening. These population-based data clearly indicate the risk of retinopathy worsening in a short interval (four years) in a large proportion of people with older-onset diabetes, a group previously thought to be relatively protected from retinopathy. Such patients who make up the largest proportion of diabetic patients in the United States need examination when diabetes is first diagnosed and regular follow-up.
Similar articles
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.Arch Ophthalmol. 1989 Feb;107(2):237-43. doi: 10.1001/archopht.1989.01070010243030. Arch Ophthalmol. 1989. PMID: 2916977
-
The Wisconsin epidemiologic study of diabetic retinopathy: an update.Aust N Z J Ophthalmol. 1990 Feb;18(1):19-22. doi: 10.1111/j.1442-9071.1990.tb00579.x. Aust N Z J Ophthalmol. 1990. PMID: 2357354
-
The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy.Arch Ophthalmol. 1994 Sep;112(9):1217-28. doi: 10.1001/archopht.1994.01090210105023. Arch Ophthalmol. 1994. PMID: 7619101
-
Epidemiology of proliferative diabetic retinopathy.Diabetes Care. 1992 Dec;15(12):1875-91. doi: 10.2337/diacare.15.12.1875. Diabetes Care. 1992. PMID: 1464243 Review.
-
The Wisconsin epidemiological study of diabetic retinopathy: a review.Diabetes Metab Rev. 1989 Nov;5(7):559-70. doi: 10.1002/dmr.5610050703. Diabetes Metab Rev. 1989. PMID: 2689119 Review.
Cited by
-
Retinal oxygen saturation changes progressively over time in diabetic retinopathy.PLoS One. 2021 May 12;16(5):e0251607. doi: 10.1371/journal.pone.0251607. eCollection 2021. PLoS One. 2021. PMID: 33979414 Free PMC article.
-
A multiscale decomposition approach to detect abnormal vasculature in the optic disc.Comput Med Imaging Graph. 2015 Jul;43:137-49. doi: 10.1016/j.compmedimag.2015.01.001. Epub 2015 Jan 20. Comput Med Imaging Graph. 2015. PMID: 25698545 Free PMC article.
-
Vitreous levels of vascular endothelial growth factor, stromal cell-derived factor-1α, and angiopoietin-like protein 2 in patients with active proliferative diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2021 Jan;259(1):53-60. doi: 10.1007/s00417-020-04889-0. Epub 2020 Aug 19. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 32813109
-
[Chronic complications of type 2 diabetes mellitus. Clinical course after 5 years of follow-up].Aten Primaria. 2000 Apr 15;25(6):405-11. doi: 10.1016/s0212-6567(00)78531-3. Aten Primaria. 2000. PMID: 10857231 Free PMC article. Spanish.
-
Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern.Oman Med J. 2019 Jan;34(1):20-25. doi: 10.5001/omj.2019.04. Oman Med J. 2019. PMID: 30671180 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical